Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 18/20 | 0.79 |
| ▸ | CA4 | P22748 | 3/20 | 0.79 |
| ▸ | CA1 | P00915 | 3/20 | 0.72 |
| ▸ | CA12 | O43570 | 2/20 | 0.72 |
| ▸ | CA6 | P23280 | 2/20 | 0.72 |
| ▸ | CA5A | P35218 | 2/20 | 0.72 |
| ▸ | CA7 | P43166 | 2/20 | 0.72 |
| ▸ | CA9 | Q16790 | 2/20 | 0.72 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.72 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.72 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3576264 | 1.00 | CA2 (0.79) | CA2CA4CA1CA12CA6 | |
| SCHEMBL3586580 | 1.00 | CA2 (0.79) | CA2CA4CA1CA12CA6 | |
| SCHEMBL7847722 | 0.94 | CA2 (0.69) | CA2CA4CA1CA12CA6 | |
| SCHEMBL7517336 | 0.94 | CA2 (0.69) | CA2CA4CA1CA12CA6 | |
| SCHEMBL8950315 | 0.90 | CA2 (0.64) | CA2CA4CA1CA12CA6 | |
| N-Desethyl Brinzolamide SCHEMBL2631262 | 0.88 | CA2 (1.00) | CA2CA4CA1CA12CA6 | |
| SCHEMBL9600441 | 0.87 | CA2 (0.70) | CA2CA4CA1CA12CA6 | |
| SCHEMBL9595980 | 0.86 | CA2 (0.60) | CA2CA4CA1CA12CA6 | |
| N-Desethyl Brinzolamide SCHEMBL31252384 | 0.86 | CA2 (0.90) | CA2CA4CA1CA12CA6 | |
| SCHEMBL31252424 | 0.85 | CA2 (0.82) | CA2CA4CA1CA12CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638444-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | Bristol-Myers Squibb Company (US) | 2025-10-29 | — | — | EP | claimed |
| WO-2025119860-A1 | LIQUID AGROCHEMICAL FORMULATIONS COMPRISING FLUPYRADIFURONE | BAYER AKTIENGESELLSCHAFT (DE) | 2025-06-12 | — | — | WO | claimed |
| CN-120124945-A | Intelligent planning method for geological mineral exploration analysis model | 山东省地质矿产勘查开发局第六地质大队(山东省第六地质矿产勘查院) | 2025-06-10 | — | — | CN | claimed |
| WO-2025054678-A1 | PLANT BIOSTIMULATING COMPOSITIONS AND USES THEREOF | New Wave Biotech Pty Ltd (AU) | 2025-03-20 | — | — | WO | claimed |
| WO-2024147395-A1 | SILICONE RUBBER HAVING SHAPE MEMORY PROPERTIES, AND METHOD FOR MANUFACTURING SAME | 주식회사 티엠디랩 | 2024-07-11 | — | — | WO | claimed |
| WO-2024137724-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-06-27 | — | — | WO | claimed |
| EP-4343814-A1 | METHOD OF PROCESSING SUBSTRATE, METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE, PROGRAM, AND SUBSTRATE PROCESSING APPARATUS | Kokusai Electric Corp. (JP) | 2024-03-27 | — | — | EP | claimed |
| EP-4126324-A1 | PREPARATION OF MAGNETIC CORE-SHELL PARTICLES | Université de Liège (BE) | 2023-02-08 | — | — | EP | claimed |
| CN-115066295-A | Catalyst having hexagonal structure and catalyst metal supported on support, and method for producing same | 韩国科学技术研究院 | 2022-09-16 | — | — | CN | claimed |
| EP-4034585-A1 | HARDENER FOR EPOXY CASTING RESINS | Sika Technology AG (CH) | 2022-08-03 | — | — | EP | claimed |
| CN-114118163-A | Optical fiber intrusion detection method based on machine learning | 桂林电子科技大学 | 2022-03-01 | — | — | CN | claimed |
| US-20100009977-A1 | Process for the preparation of (R)-(+)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide. | USV LTD. (IN) | 2010-01-14 | — | — | US | claimed |
| CN-122035374-A | But medium-sized unmanned aerial vehicle general electromagnetic emission platform of quick assembly disassembly | 江西航空研究院 | 2026-05-15 | — | — | CN | disclosed |
| CN-121728821-B | Semiconductor device and method for manufacturing the same | 合肥晶合集成电路股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-122047131-A | Method, device, medium, equipment and product for determining parameters of circuit simulation model | 成都新紫光半导体科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-122047542-A | High-precision aerodynamic design method for appearance of aircraft based on quantum discrete adiabatic algorithm | 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) | 2026-05-15 | — | — | CN | disclosed |
| US-5424448-A | Preparation of carbonic anhydrase inhibitors | ALCON LABORATORIES, INC. (US) | 1995-06-13 | — | — | US | disclosed |
| US-5378703-A | FOR CONTROLLING INTRAOCULAR PRESSURE | ALCON LABORATORIES, INC. (US) | 1995-01-03 | — | — | US | disclosed |
| EP-0617038-A1 | Preparation of carbonic anhydrase inhibitors | ALCON LABORATORIES, INC. (US) | 1994-09-28 | — | — | EP | disclosed |
| US-5344929-A | Preparation of carbonic anhydrase inhibitors | ALCON LABORATORIES, INC. (US) | 1994-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009977-A1 | Process for the preparation of (R)-(+)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide. | SULT1E1, SULT1A1, SULT2A1 | CA2 1631/4885CA4 709/4885CA1 2298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.